All In MedTech

Device Trial Radar · NCT07385313

Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures

Randomized Prospective Evaluation of Ovine Forestomach Matrix (OFM) and NPWT to Accelerate Tissue Coverage Over Exposed Structures

Last checked: Nov 20, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Mar 31, 2026

Primary completion

Mar 2027

Study completion Apr 2027

Sponsor

Lead sponsor
Aroa Biosurgery LimitedNot on our public-company list
Sponsor type
Industry
Collaborators
Coalition for National Trauma Research
First posted
Feb 4, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Demonstrate faster tissue coverage of exposed structures using OFM in combination with negative pressure wound therapy (NPWT), versus NPWT alone

Conditions

  • Soft Tissue Defects
  • Soft Tissue Wounds
  • Traumatic Soft Tissue Defect

Interventions

  • Myriad™ applied in conjunction with NPWTDevice

    Myriad™ applied in conjunction with NPWT ('Myriad+NPWT')

  • NPWT AloneDevice

    Control Arm: NPWT alone ('NPWT')

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tissue CoverageTime frame: Up to 56 days/ 8 week follow up

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of Colorado-Anschutz Medical Campus

    Aurora, Colorado · Recruiting

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.